These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1358444)

  • 1. Improved isovolumetric relaxation in canine reperfused myocardium after beta 1 adrenergic stimulation.
    Böhm M
    Cardiovasc Res; 1992 Mar; 26(3):273-8. PubMed ID: 1358444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery.
    Schäfer S; Linder C; Heusch G
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):206-13. PubMed ID: 2146513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia.
    Ehring T; Böhm M; Heusch G
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):63-74. PubMed ID: 1383632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the partial beta 1-adrenergic agonist, xamoterol, on hemodynamics and regional myocardial function during acute coronary occlusion in dogs.
    Miura T; Matsuzaki M; Toma Y; Yonezawa F; Kohno M; Katayama K; Ozaki M; Kumada T; Kusukawa R
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):182-7. PubMed ID: 1689411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged abnormalities of left ventricular diastolic wall thinning in the "stunned" myocardium in conscious dogs: time course and relation to systolic function.
    Charlat ML; O'Neill PG; Hartley CJ; Roberts R; Bolli R
    J Am Coll Cardiol; 1989 Jan; 13(1):185-94. PubMed ID: 2909566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of xamoterol, a beta 1-adrenoceptor partial agonist, on myocardial pH decreased by coronary occlusion in dogs.
    Sashida H; Sakai K; Hino T; Abiko Y
    Pharmacology; 1986; 33(6):301-10. PubMed ID: 2882527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic dysfunction of stunned myocardium.
    Ehring T; Schulz R; Schipke JD; Heusch G
    Am J Cardiovasc Pathol; 1993; 4(4):358-66. PubMed ID: 8305199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
    de Feyter PJ; Serruys PW; Suryapranata H
    Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
    Pouleur H; van Eyll C; Hanet C; Cheron P; Charlier AA; Rousseau MF
    Circulation; 1988 May; 77(5):1081-9. PubMed ID: 2896076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contraction of stunned myocardium: isovolumetric bulging and wasted ejection shortening in dog heart.
    Chen G; Askenase AD; Chen K; Horowitz LN; Segal BL
    Cardiovasc Res; 1992 Feb; 26(2):115-25. PubMed ID: 1571931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy.
    Pouleur H; Etienne J; Van Mechelen H; Gurné O; Rousseau MF
    Circulation; 1990 Feb; 81(2 Suppl):III87-92. PubMed ID: 1967560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine on diastolic function during brief periods of flow-limiting ischemia in the conscious dog.
    Applegate RJ; Walsh RA; O'Rourke RA
    Circulation; 1987 Dec; 76(6):1409-21. PubMed ID: 3677362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration.
    Bolli R; Zhu WX; Myers ML; Hartley CJ; Roberts R
    Am J Cardiol; 1985 Dec; 56(15):964-8. PubMed ID: 2866704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between global and regional systolic and diastolic ventricular function during coronary occlusion and reperfusion.
    Verani MS; Bolli R; Tadros S; Myers ML; Borges Neto S; Jain A; Phillips L; Roberts R
    Am Heart J; 1987 Oct; 114(4 Pt 1):687-95. PubMed ID: 2959131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic stimulation of reperfused myocardium after 2-hour ischemia.
    LaBruno S; Naim KL; Li JK; Drzewiecki G; Kedem J
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):535-42. PubMed ID: 9781921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary flow velocity patterns immediately after reperfusion reflect the pathologic characteristics of reperfused myocardium in canine models of acute myocardial infarction.
    Sakabe K; Wakatsuki T; Shinohara H; Ikata J; Fujinaga H; Oishi Y; Toyoshima T; Nishikado A; Oki T; Ito S
    Coron Artery Dis; 1998; 9(1):21-7. PubMed ID: 9589187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine depresses myocardial contractility and prolongs isovolumetric relaxation in conscious dogs with partial autonomic nervous system blockade.
    Pagel PS; Power MW; Kenny D; Warltier DC
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):25-34. PubMed ID: 1383628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on diastolic dysfunction: a new approach to heart failure therapy.
    Pouleur H; Hanet C; Gurné O; Rousseau MF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):41S-52S. PubMed ID: 2572254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.